The Journal of Immunology, Vol 157, Issue 2 679-688, Copyright © 1996 by American Association of Immunologists

ARTICLES

A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule

M Vergelli, H Le, JM van Noort, S Dhib-Jalbut, H McFarland and R Martin
Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA.

CD56 is a member of the neural cell adhesion molecule family expressed on cells of the central nervous system and also on NK cells. Previous studies suggest the involvement of CD56 in effector-to-target cell conjugation mediated by NK cells. It was shown recently that CD56 is also expressed by subpopulations of CD8+ and CD4+ T cells. The present study describes the functional characteristics of CD4+CD56+ T cell lines established from blood of multiple sclerosis patients by stimulation with myelin basic protein (MBP). CD4+CD56+, MBP-specific T cell lines were able to lyse MBP-pulsed target cells in an HLA class II- restricted fashion. At the same time, they mediated MHC-unrestricted lysis of CD56+ target cells such as CD56+ lymphoid or glial tumor cells, but not of the typical NK target, K562. A number of experimental results including separation of CD4+CD56+ T cells into CD56 high and low expressing populations, cold target inhibition, as well as killing of CD56-transfected cells indicate that homotypic CD56 interactions are involved in the MHC-unrestricted lysis. CD56 interactions are not sufficient but are required for effector/target interaction. Our findings raise the possibility that CD4+CD56+ T cells sharing properties of both typical Ag-specific Th0-like T cells and NK cells might be involved in damage of tissues expressing CD56/neural cell adhesion molecule, such as the central nervous system. Thus, we provide evidence for a novel mechanism that could lead to organ-specific autoreactivity.

This article has been cited by other articles:

				Y. S. Kap, P. Smith, S. A. Jagessar, E. Remarque, E. Blezer, G. J. Strijkers, J. D. Laman, R. Q. Hintzen, J. Bauer, H. P. M. Brok, et al. Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34-56-Specific Cytotoxic T Cells J. Immunol., February 1, 2008; 180(3): 1326 - 1337. [Abstract] [Full Text] [PDF]

				C. Papewalis, B. Jacobs, M. Wuttke, E. Ullrich, T. Baehring, R. Fenk, H. S. Willenberg, S. Schinner, M. Cohnen, J. Seissler, et al. IFN-{alpha} Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo J. Immunol., February 1, 2008; 180(3): 1462 - 1470. [Abstract] [Full Text] [PDF]

				V. Vargas-Leal, R. Bruno, T. Derfuss, M. Krumbholz, R. Hohlfeld, and E. Meinl Expression and Function of Glial Cell Line-Derived Neurotrophic Factor Family Ligands and Their Receptors on Human Immune Cells J. Immunol., August 15, 2005; 175(4): 2301 - 2308. [Abstract] [Full Text] [PDF]

				D. Atanackovic, A. Block, A. de Weerth, C. Faltz, D. K. Hossfeld, and S. Hegewisch-Becker Characterization of Effusion-Infiltrating T Cells: Benign versus Malignant Effusions Clin. Cancer Res., April 15, 2004; 10(8): 2600 - 2608. [Abstract] [Full Text] [PDF]

				K. U. Saikh, B. Dyas, T. Kissner, and R. G. Ulrich CD56+-T-Cell Responses to Bacterial Superantigens and Immune Recognition of Attenuated Vaccines Clin. Vaccine Immunol., November 1, 2003; 10(6): 1065 - 1073. [Abstract] [Full Text] [PDF]

				A. Jurewicz, W. E. Biddison, and J. P. Antel MHC Class I-Restricted Lysis of Human Oligodendrocytes by Myelin Basic Protein Peptide-Specific CD8 T Lymphocytes J. Immunol., March 15, 1998; 160(6): 3056 - 3059. [Abstract] [Full Text] [PDF]

				J. P. Antel, E. McCrea, U. Ladiwala, Y.-f. Qin, and B. Becher Non-MHC-Restricted Cell-Mediated Lysis of Human Oligodendrocytes In Vitro: Relation with CD56 Expression J. Immunol., February 15, 1998; 160(4): 1606 - 1611. [Abstract] [Full Text] [PDF]